Titre : Éphrine A3

Éphrine A3 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Checklist
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Éphrine A3 : Questions médicales les plus fréquentes", "headline": "Éphrine A3 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Éphrine A3 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-21", "dateModified": "2025-02-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Éphrine A3" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Éphrines", "url": "https://questionsmedicales.fr/mesh/D036342", "about": { "@type": "MedicalCondition", "name": "Éphrines", "code": { "@type": "MedicalCode", "code": "D036342", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.500" } } }, "about": { "@type": "MedicalCondition", "name": "Éphrine A3", "alternateName": "Ephrin-A3", "code": { "@type": "MedicalCode", "code": "D036384", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Elena B Pasquale", "url": "https://questionsmedicales.fr/author/Elena%20B%20Pasquale", "affiliation": { "@type": "Organization", "name": "Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. elenap@sbpdiscovery.org." } }, { "@type": "Person", "name": "Katsuaki Ieguchi", "url": "https://questionsmedicales.fr/author/Katsuaki%20Ieguchi", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, Tokyo Women's Medical University, Tokyo, Japan. kieguchi@twmu.ac.jp." } }, { "@type": "Person", "name": "Yoshiro Maru", "url": "https://questionsmedicales.fr/author/Yoshiro%20Maru", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, Tokyo Women's Medical University, Tokyo, Japan. maru.yoshiro@twmu.ac.jp." } }, { "@type": "Person", "name": "Stamatios Theocharis", "url": "https://questionsmedicales.fr/author/Stamatios%20Theocharis", "affiliation": { "@type": "Organization", "name": "First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 157 72 Athens, Greece." } }, { "@type": "Person", "name": "Liu Yang", "url": "https://questionsmedicales.fr/author/Liu%20Yang", "affiliation": { "@type": "Organization", "name": "Department of Ophthalmology, Peking University First Hospital, Beijing, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Effect of the implementation of a checklist in the prehospital management of a traumatised patient.", "datePublished": "2023-07-25", "url": "https://questionsmedicales.fr/article/37517114", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajem.2023.07.034" } }, { "@type": "ScholarlyArticle", "name": "Ethical considerations on artificial intelligence in dentistry: A framework and checklist.", "datePublished": "2023-06-22", "url": "https://questionsmedicales.fr/article/37355089", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jdent.2023.104593" } }, { "@type": "ScholarlyArticle", "name": "Fitness checklist model for spontaneous breathing tests in pediatrics.", "datePublished": "2023-03-01", "url": "https://questionsmedicales.fr/article/37712731", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5935/2965-2774.20230312-en" } }, { "@type": "ScholarlyArticle", "name": "Using checklists to improve care in the nonoperating room environment.", "datePublished": "2022-07-05", "url": "https://questionsmedicales.fr/article/35787585", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/ACO.0000000000001154" } }, { "@type": "ScholarlyArticle", "name": "Paediatric percutaneous nephrolithotomy (P-PCNL) reporting checklist.", "datePublished": "2023-11-21", "url": "https://questionsmedicales.fr/article/37987596", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2340/sju.v58.13392" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Protéines et peptides de signalisation intercellulaire", "item": "https://questionsmedicales.fr/mesh/D036341" }, { "@type": "ListItem", "position": 4, "name": "Éphrines", "item": "https://questionsmedicales.fr/mesh/D036342" }, { "@type": "ListItem", "position": 5, "name": "Éphrine A3", "item": "https://questionsmedicales.fr/mesh/D036384" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Éphrine A3 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Éphrine A3", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Éphrine A3", "description": "Comment diagnostiquer une anomalie d'éphrine A3 ?\nQuels examens sont recommandés pour évaluer l'éphrine A3 ?\nY a-t-il des biomarqueurs associés à l'éphrine A3 ?\nQuels symptômes peuvent indiquer un problème avec l'éphrine A3 ?\nPeut-on utiliser l'imagerie pour évaluer l'éphrine A3 ?", "url": "https://questionsmedicales.fr/mesh/D036384?mesh_terms=Checklist&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Éphrine A3", "description": "Quels sont les symptômes d'une dysfonction d'éphrine A3 ?\nL'éphrine A3 est-elle liée à des maladies spécifiques ?\nComment l'éphrine A3 affecte-t-elle le système nerveux ?\nDes troubles comportementaux peuvent-ils être liés à l'éphrine A3 ?\nL'éphrine A3 influence-t-elle le développement cérébral ?", "url": "https://questionsmedicales.fr/mesh/D036384?mesh_terms=Checklist&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Éphrine A3", "description": "Peut-on prévenir les troubles liés à l'éphrine A3 ?\nY a-t-il des facteurs environnementaux influençant l'éphrine A3 ?\nComment le mode de vie affecte-t-il l'éphrine A3 ?\nDes conseils nutritionnels peuvent-ils aider ?\nL'éducation prénatale peut-elle prévenir des troubles ?", "url": "https://questionsmedicales.fr/mesh/D036384?mesh_terms=Checklist&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Éphrine A3", "description": "Quels traitements ciblent l'éphrine A3 ?\nPeut-on modifier l'expression de l'éphrine A3 ?\nY a-t-il des essais cliniques sur l'éphrine A3 ?\nQuels médicaments peuvent affecter l'éphrine A3 ?\nL'éphrine A3 peut-elle être une cible thérapeutique ?", "url": "https://questionsmedicales.fr/mesh/D036384?mesh_terms=Checklist&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Éphrine A3", "description": "Quelles complications peuvent survenir avec l'éphrine A3 ?\nL'éphrine A3 est-elle impliquée dans des cancers ?\nDes troubles cognitifs peuvent-ils être des complications ?\nComment les complications sont-elles gérées ?\nY a-t-il des risques de récidive avec l'éphrine A3 ?", "url": "https://questionsmedicales.fr/mesh/D036384?mesh_terms=Checklist&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Éphrine A3", "description": "Quels sont les facteurs de risque pour l'éphrine A3 ?\nL'hérédité joue-t-elle un rôle dans les troubles d'éphrine A3 ?\nLes toxines environnementales affectent-elles l'éphrine A3 ?\nLe stress peut-il influencer l'éphrine A3 ?\nY a-t-il des prédispositions génétiques pour l'éphrine A3 ?", "url": "https://questionsmedicales.fr/mesh/D036384?mesh_terms=Checklist&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie d'éphrine A3 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses de tissus peuvent être utilisés pour détecter des anomalies." } }, { "@type": "Question", "name": "Quels examens sont recommandés pour évaluer l'éphrine A3 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'immunohistochimie et la PCR sont souvent utilisés pour évaluer l'expression de l'éphrine A3." } }, { "@type": "Question", "name": "Y a-t-il des biomarqueurs associés à l'éphrine A3 ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'éphrine A3 elle-même peut servir de biomarqueur dans certaines pathologies neurologiques." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec l'éphrine A3 ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles neurologiques ou des anomalies de développement peuvent indiquer un problème." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour évaluer l'éphrine A3 ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie cérébrale peut aider à visualiser des anomalies associées à des dysfonctionnements de l'éphrine A3." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une dysfonction d'éphrine A3 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des troubles cognitifs, des problèmes de coordination et des retards de développement." } }, { "@type": "Question", "name": "L'éphrine A3 est-elle liée à des maladies spécifiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies d'éphrine A3 sont associées à des maladies neurodégénératives et des cancers." } }, { "@type": "Question", "name": "Comment l'éphrine A3 affecte-t-elle le système nerveux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle joue un rôle dans la formation des synapses et la plasticité neuronale, influençant le comportement." } }, { "@type": "Question", "name": "Des troubles comportementaux peuvent-ils être liés à l'éphrine A3 ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dysfonctionnements de l'éphrine A3 peuvent entraîner des troubles du comportement." } }, { "@type": "Question", "name": "L'éphrine A3 influence-t-elle le développement cérébral ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est essentielle pour le développement normal des circuits neuronaux dans le cerveau." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés à l'éphrine A3 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par une détection précoce et une intervention dans les cas à risque." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux influençant l'éphrine A3 ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs environnementaux comme la nutrition et les toxines peuvent influencer son expression." } }, { "@type": "Question", "name": "Comment le mode de vie affecte-t-il l'éphrine A3 ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain peut favoriser une expression normale de l'éphrine A3 et réduire les risques." } }, { "@type": "Question", "name": "Des conseils nutritionnels peuvent-ils aider ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en nutriments peut soutenir la santé neuronale et l'éphrine A3." } }, { "@type": "Question", "name": "L'éducation prénatale peut-elle prévenir des troubles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation prénatale sur les risques environnementaux peut aider à prévenir des troubles liés à l'éphrine A3." } }, { "@type": "Question", "name": "Quels traitements ciblent l'éphrine A3 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des médicaments ciblant les voies de signalisation peuvent être envisagés." } }, { "@type": "Question", "name": "Peut-on modifier l'expression de l'éphrine A3 ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des approches pharmacologiques peuvent moduler l'expression de l'éphrine A3 dans certaines conditions." } }, { "@type": "Question", "name": "Y a-t-il des essais cliniques sur l'éphrine A3 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des essais cliniques sont en cours pour évaluer des traitements ciblant l'éphrine A3 dans diverses pathologies." } }, { "@type": "Question", "name": "Quels médicaments peuvent affecter l'éphrine A3 ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments anticancéreux et neuroprotecteurs peuvent influencer l'activité de l'éphrine A3." } }, { "@type": "Question", "name": "L'éphrine A3 peut-elle être une cible thérapeutique ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en raison de son rôle dans diverses maladies, elle est considérée comme une cible thérapeutique potentielle." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'éphrine A3 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques et des troubles de développement peuvent survenir en cas d'anomalies." } }, { "@type": "Question", "name": "L'éphrine A3 est-elle impliquée dans des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies d'éphrine A3 sont associées à certains types de cancers, notamment le gliome." } }, { "@type": "Question", "name": "Des troubles cognitifs peuvent-ils être des complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dysfonctionnements de l'éphrine A3 peuvent entraîner des troubles cognitifs sévères." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications implique des traitements symptomatiques et des interventions ciblées." } }, { "@type": "Question", "name": "Y a-t-il des risques de récidive avec l'éphrine A3 ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des risques de récidive peuvent exister dans les cas de cancers associés à des anomalies d'éphrine A3." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour l'éphrine A3 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs génétiques, environnementaux et le mode de vie peuvent influencer le risque d'anomalies." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans les troubles d'éphrine A3 ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de troubles neurologiques peuvent augmenter le risque d'anomalies." } }, { "@type": "Question", "name": "Les toxines environnementales affectent-elles l'éphrine A3 ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certaines toxines peut perturber l'expression de l'éphrine A3." } }, { "@type": "Question", "name": "Le stress peut-il influencer l'éphrine A3 ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la signalisation de l'éphrine A3 et la santé neuronale." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques pour l'éphrine A3 ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines variations génétiques peuvent prédisposer les individus à des troubles liés à l'éphrine A3." } } ] } ] }

Sources (1168 au total)

Effect of the implementation of a checklist in the prehospital management of a traumatised patient.

In October 2021, French acute care societies jointly published cognitive aids to standardise practices and limit cognitive biases to ensure greater safety in management of severe trauma patients. The ... This prospective before-and-after study study took place in a French mobile emergency and resuscitation service. All adults trauma patients referred to hospital were included. A checklist on trauma ma... One hundred and sixteen patients were included, 53 in phase I and 63 in phase II. Eleven patients did not have a checklist in phase II. The overall omission rate of checklist items was significantly l... This work shows a significant reduction in the number of omissions on the actions carried out during the management of a trauma patient in prehospital settings, allowing better adherence to the recomm...

Ethical considerations on artificial intelligence in dentistry: A framework and checklist.

Artificial Intelligence (AI) refers to the ability of machines to perform cognitive and intellectual human tasks. In dentistry, AI offers the potential to enhance diagnostic accuracy, improve patient ... Lending from existing guidance documents, an initial draft of the checklist and an explanatory paper were derived and discussed among the groups members.... The checklist was consented to in an anonymous voting process by 29 Topic Group Dental Diagnostics and Digital Dentistry, ITU/WHO Focus Group AI on Health's members. Overall, 11 principles were identi... Providers, patients, researchers, industry, and other stakeholders should consider these principles when developing, implementing, or receiving AI applications in dentistry.... While AI has become increasingly commonplace in dentistry, there are ethical concerns around its usage, and users (providers, patients, and other stakeholders), as well as the industry should consider...

Fitness checklist model for spontaneous breathing tests in pediatrics.

To evaluate whether a model of a daily fitness checklist for spontaneous breathing tests is able to identify predictive variables of extubation failure in pediatric patients admitted to a Brazilian in... This was a single-center, cross-sectional study with prospective data collection. The checklist model comprised 20 items and was applied to assess the ability to perform spontaneous breathing tests.... The sample consisted of 126 pediatric patients (85 males (67.5%)) on invasive mechanical ventilation, for whom 1,217 daily assessments were applied at the bedside. The weighted total score of the pred... The extubation failure rate with the use of this model was within what is acceptable in the literature. The daily checklist model for the spontaneous breathing test was able to identify predictive var...

Using checklists to improve care in the nonoperating room environment.

As the number and complexity of cases performed in the nonoperating room environment continue to increase to a higher share of all anesthetic procedures, checklists are needed to ensure staff and pati... Providing anesthesia care in the nonoperating room environment poses specific challenges. Closed claims data base analysis shows a higher morbidity and mortality in this setting. This is driven by the... Anesthesia in the nonoperating room environment is becoming an increasing share of total anesthesia cases. Establishing protocols and implementing site-specific checklists is emerging as a strategy in... http://links.lww.com/COAN/A89 ....

Paediatric percutaneous nephrolithotomy (P-PCNL) reporting checklist.

To develop a reporting checklist that serves to improve and standardise reporting in studies pertaining to paediatric percutaneous nephrolithotomy (PCNL).... Based on findings from systematic review of literature, a draft list of items was formulated. By process of review and revisions, a finalised version was established and consensus achieved.... The finalised version of the checklist covers four main sections, which include the following areas: study details, pre-operative, operative and post-operative information. There are 18 further sub-it... This practical tool can aid clinicians and researchers when undertaking and reviewing studies on paediatric PCNL. This is highly relevant given the current heterogeneity that exists as well as debate ...

Checklists for interpreting chest radiographs: a scoping review protocol.

What is known about checklists for interpreting chest radiographs? The question will guide the development of the inclusion criteria for the scoping review. Breaking down the scoping review question w... X-ray reporting can be standardised using checklists. Checklists may reduce the time needed to produce a comprehensive X-ray report and improve the quality and consistency of detecting abnormalities o... We will follow the methodological framework for scoping reviews originally described by Arksey and O'Malley. The scoping review will include articles that describe checklists for reducing diagnostic e... The results will be collated, summarised and discussed including any limitations of the included articles. The articles will be summarised in a table, as well as narratively. The distribution of studi... The results of the scoping review will be used to develop a checklist that will be used by medical doctors in collaboration with radiographers working in settings where there are no radiologists on-si... Scoping review protocol registered with Open Science Framework on 27 July 2022. Registration https://doi.org/10.17605/OSF.IO/JS5PQ....

Comparison of a dichotomous versus trichotomous checklist for neonatal intubation.

To compare validity evidence for dichotomous and trichotomous versions of a neonatal intubation (NI) procedural skills checklist.... NI skills checklists were developed utilizing an existing framework. Experts were trained on scoring using dichotomous and trichotomous checklists, and rated recordings of 23 providers performing simu... During rater training, raters gave significantly higher scores on better provider performance in standardized videos (both p < 0.001). When utilized to evaluate study participants' simulated NI attemp... Neither dichotomous or trichotomous checklist was superior in discriminating provider NI skill when compared to GSA, EPA, or airway visualization assessment. Sum scores from dichotomous checklists may...

Collaboration Scripts or Checklists to Engage Novice Observers in Immersive Simulation?

In simulation, students often observe their peers perform a task. It is still unclear how different types of instructional guidance can turn the observational phase into an active learning experience ... Second-year pharmacy students ( N = 162) were randomly assigned to 1 of 4 conditions when observing a simulation: collaboration scripts (heuristic to analyze in dyads while observing), checklists, bot... Intrinsic cognitive load was significantly lower for checklists (M = 3.6/10) than for scripts (M = 4.7/10) or scripts and checklists combined (M = 4.7/10). Extraneous cognitive load was significantly ... With or without guidance, observers are actively engaged with the simulation, but their effort differed depending on instructions. When choosing between checklists or collaboration scripts, educators ...

Development of an Evidence-Based Pediatric Preoperative Risk Assessment Checklist.

To describe how a pediatric preoperative risk assessment (PPRA) checklist was developed to inform perianesthesia nurses of potential postanesthesia care unit (PACU) respiratory complications.... Evidence-based practice approach.... A systematic search was conducted using PubMed, CINAHL and Cochrane Library databases for this project. In addition, an integrative review process was conducted to develop an assessment checklist of e... Eleven risk categories were established: Age, American Society of Anesthesiologists Physical Status, gender, general anesthesia, airway comorbidities, syndromes/congenital anomalies, pulmonary comorbi... The PPRA checklist presents a rapid way to communicate through handoff the preoperative "big picture" to interpret children's acuity and comprehensive risk for significant pediatric respiratory advers...

Construction and validation of a checklist for the management of totally implanted catheters in children.

to construct and validate the content of a checklist for the management of totally implanted catheters in hospitalized children and adolescents.... methodological research conducted from October 2021 to December 2022 in two stages: development of the instrument with care guidelines and content validation of the checklist. The instrument, containi... the final checklist included four domains and 22 checklist items, validated with a Content Validity Index of 0.98. The overall evaluation of the instrument presented a global score of 9.9.... the validation and application of instruments that standardize procedures, in addition to supporting professionals, promote autonomy and quality of care for children and adolescents using this device....